Initiating, Intensifying and De-Intensifying Insulin | Recorded Webinar-Initiating, Intensifying and De-Intensifying Insulin

Video Transcription

Video Summary

In this video webinar, Dr. Bob Gabay, the Chief Scientific and Medical Officer at the American Diabetes Association, moderates a discussion on overcoming therapeutic inertia in diabetes management, supported by Sanofi Diabetes. The focus is on initiating, intensifying, and de-intensifying insulin therapy to achieve glycemic goals. The concept of therapeutic inertia is discussed, which refers to the delay or inaction in adjusting therapy when blood sugar goals are not met. The webinar includes case studies highlighting challenges faced by individuals like Richard, a homeless man with diabetes. The panelists emphasize the importance of comprehensive care, addressing cost barriers, engaging patients in their care, and utilizing a team-based approach to diabetes management, with a focus on optimizing therapy and addressing social determinants of health. Recommendations include leveraging resources at federally qualified health centers, exploring affordable insulin options, and collaborating with pharmacists to enhance patient care. Strategies to mitigate weight gain associated with insulin therapy and adjusting regimen based on patient needs are also discussed. The audience is encouraged to seek further resources online and engage in team-based care to improve outcomes for patients with diabetes.

Keywords

webinar

Dr. Bob Gabay

therapeutic inertia

diabetes management

insulin therapy

glycemic goals

case studies

comprehensive care

social determinants of health